Silo Pharma, Inc. Annual Income Tax Expense (Benefit) in USD for 2021

Taxonomy & unit: us-gaap: USD
Description: Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary: Silo Pharma, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate for 2021.
Silo Pharma, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $906K, a 50.3% increase year-over-year.

Income Tax Expense (Benefit), Annual (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2021	$24.9K			Jan 1, 2021	Dec 31, 2021	10-K	2023-03-24

* An asterisk sign (*) next to the value indicates that the value is likely invalid.